The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
The direct cost of epilepsy in the United States: A systematic review of estimates
Open accessAbstract
Summary: Objective: To develop estimates of the direct cost of epilepsy in the United States for the general epilepsy population and sub‐populations by systematically comparing similarities and differences in types of estimates and estimation methods from recently published studies. Methods: Papers published since 1995 were identified by systematic literature search. Information on types of estimates, study designs, data sources, types of epilepsy, and estimation methods was extracted from each study. Annual per person cost estimates from methodologically similar studies were identified, converted to 2013 U.S. dollars, and compared. Results: From 4,104 publications discovered in the literature search, 21 were selected for review. Three were added that were published after the search. Eighteen were identified that reported estimates of average annual direct costs for the general epilepsy population in the United States. For general epilepsy populations (comprising all clinically defined subgroups), total direct healthcare costs per person ranged from $10,192 to $47,862 and epilepsy‐specific costs ranged from $1,022 to $19,749. Four recent studies using claims data from large general populations yielded relatively similar epilepsy‐specific annual cost estimates ranging from $8,412 to $11,354. Although more difficult to compare, studies examining direct cost differences for epilepsy sub‐populations indicated a consistent pattern of markedly higher costs for those with uncontrolled or refractory epilepsy, and for those with comorbidities. Significance: This systematic review found that various approaches have been used to estimate the direct costs of epilepsy in the United States. However, recent studies using large claims databases and similar methods allow estimation of the direct cost burden of epilepsy for the general disease population, and show that it is greater for some patient subgroups. Additional research is needed to further understand the broader economic burden of epilepsy and how it varies across subpopulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
How common are the "common" neurologic disorders?
Hirtz, D., Thurman, D. J., Gwinn-Hardy, K., Mohamed, M., Chaudhuri, A. R., & Zalutsky, R. (2007) · Neurology · doi:10.1212/01.wnl.0000252807.38124.a3 · Cited by 1,365
HOW COMMON ARE THE “COMMON” NEUROLOGIC DISORDERS?
Kaplin, A. I., & Williams, M. (2007) · Neurology · doi:10.1212/01.wnl.0000278071.91524.4d · Cited by 1,131
Standards for epidemiologic studies and surveillance of epilepsy
Thurman, D. J., Beghi, E., Begley, C. E., Berg, A. T., Buchhalter, J. R., Ding, D., Hesdorffer, D. C., Hauser, W. A., Kazis, L., Kobau, R., et al. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03121.x · Cited by 1,014
Self-citationEpilepsy across the spectrum: Promoting health and understanding.
England, M. J., Liverman, C. T., Schultz, A. M., & Strawbridge, L. M. (2012) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2012.06.016 · Cited by 732
Begley, C. E., Famulari, M., Annegers, J. F., Lairson, D. R., Reynolds, T. F., Coan, S., Dubinsky, S., Newmark, M. E., Leibson, C., So, E. L., et al. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00166.x · Cited by 599
Self-citationMortality of Epilepsy in Developed Countries: A Review
Forsgren, L., Hauser, W. A., Olafsson, E., Sander, J. W. A. S., Sillanpää, M., & Tomson, T. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00403.x · Cited by 282
Epilepsy surveillance among adults--19 States, Behavioral Risk Factor Surveillance System, 2005.
Kobau, R., Zahran, H. S., Thurman, D. J., Zack, M. M., Henry, T. R., Schachter, S. C., & Price, P. H. (2008) · PubMed · Cited by 269
Cost of Epilepsy: A Systematic Review
Strzelczyk, A., Reese, J. P., Dodel, R., & Hamer, H. M. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826060-00002 · Cited by 244
Cost of Epilepsy in the United States: A Model Based on Incidence and Prognosis
Begley, C. E., Annegers, J. F., Lairson, D. R., Reynolds, T. F., & Hauser, W. A. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb01794.x · Cited by 242
Self-citationPrevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population
Davis, K. L., Candrilli, S. D., & Edin, H. M. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2007.01414.x · Cited by 241
Faught, R. E., Weiner, J. R., Guérin, A., Cunnington, M. C., & Duh, M. S. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01794.x · Cited by 226
Recommendations for optimal ICD codes to study neurologic conditions: A systematic review
St. Germaine-Smith, C., Metcalfe, A., Pringsheim, T., Roberts, J. I., Beck, C. A., Hemmelgarn, B. R., McChesney, J., Quan, H., & Jette, N. (2012) · Neurology · doi:10.1212/wnl.0b013e3182684707 · Cited by 206
Estimating the Cost of Epilepsy in Europe: A Review with Economic Modeling
Pugliatti, M., Beghi, E., Forsgren, L., Ekman, M., & Sobocki, P. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01251.x · Cited by 197
Healthcare utilization and costs in adults with stable and uncontrolled epilepsy
Cramer, J. A., Wang, Z. J., Chang, E., Powers, A., Copher, R., Cherepanov, D., & Broder, M. S. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.09.046 · Cited by 181
Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy
Ettinger, A. B., Manjunath, R., Candrilli, S. D., & Davis, K. L. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.10.021 · Cited by 136
Development and validation of a case definition for epilepsy for use with administrative health data
Reid, A. Y., Smith, C., Liu, M., Sadiq, S., Quan, H., Wiebe, S., Faris, P., Dean, S., & Jetté, N. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.05.009 · Cited by 127
Economic impact of epilepsy in the United States
Yoon, D., Frick, K. D., Carr, D. A., & AUSTIN, J. K. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02159.x · Cited by 123
Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization
Manjunath, R., Paradis, P. E., Parisé, H., Lafeuille, M., Bowers, B., Duh, M. S., Lefèbvre, P., & Faught, E. (2012) · Neurology · doi:10.1212/wnl.0b013e318271f77e · Cited by 116
Developing a Computer Algorithm to Identify Epilepsy Cases in Managed Care Organizations
Holden, E. W., Grossman, E., Nguyen, H., Gunter, M. J., Grebosky, B., Worley, A. V., Nelson, L. S., Robinson, S. B., & Thurman, D. J. (2005) · Disease Management · doi:10.1089/dis.2005.8.1 · Cited by 114
Cost of refractory epilepsy in adults in the USA
Murray, M. I., Halpern, M. T., & Leppik, I. E. (1996) · Epilepsy Research · doi:10.1016/0920-1211(95)00090-9 · Cited by 111
Epilepsy in Adults and Access to Care—United States, 2010
(2013) · JAMA · doi:10.1001/jama.2012.147846 · Cited by 109
Kee, V. R., Gilchrist, B., Granner, M. A., Sarrazin, N. R., & Carnahan, R. M. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2329 · Cited by 100
Healthcare utilization and costs in children with stable and uncontrolled epilepsy
Cramer, J. A., Wang, Z. J., Chang, E. Y., Powers, A., Copher, R. M., Cherepanov, D., & Broder, M. S. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.01.016 · Cited by 84
Economic Burden of Epilepsy among the Privately Insured in the US
Ivanova, J. I., Birnbaum, H. G., Kidolezi, Y., Qiu, Y., Mallett, D. A., & Caleo, S. (2010) · PharmacoEconomics · doi:10.2165/11535570-000000000-00000 · Cited by 71
Lee, W. C., Arcona, S., Thomas, S. K., Wang, Q., Hoffmann, M. S., & Pashos, C. L. (2005) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2005.04.002 · Cited by 68
Chen, S., Wu, N., Boulanger, L., & Sacco, P. (2012) · Journal of Medical Economics · doi:10.3111/13696998.2012.751918 · Cited by 62
Ivanova, J. I., Birnbaum, H. G., Kidolezi, Y., Qiu, Y., Mallett, D. A., & Caleo, S. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02422.x · Cited by 54
Economic Differences in Direct and Indirect Costs Between People With Epilepsy and Without Epilepsy
Libby, A. M., Ghushchyan, V. H., McQueen, R. B., Slejko, J. F., Bainbridge, J. L., & Campbell, J. D. (2012) · Medical Care · doi:10.1097/mlr.0b013e31826c8613 · Cited by 36
Wilner, A. N., Sharma, B. K., Thompson, A. R., Soucy, A., & Krueger, A. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.08.131 · Cited by 36
Toward an Integrated Public Health Approach for Epilepsy in the 21st Century
Koh, H. K., Kobau, R., Whittemore, V., Mann, M. Y., Johnson, J. G., Hutter, J. D., & Jones, W. K. (2014) · Preventing Chronic Disease · doi:10.5888/pcd11.140270 · Cited by 32
Vivas, A. C., Baaj, A. A., Benbadis, S. R., & Vale, F. Ĺ. (2012) · Neurosurgical FOCUS · doi:10.3171/2012.1.focus11322 · Cited by 31
Kleinman, N. L., Sadosky, A., Seid, J., Martin, R. C., & Labiner, D. M. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.04.019 · Cited by 14
Cited by
Zack, M. M., & Kobau, R. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6631a1 · Cited by 709
Metadata
- Authors
- Begley, C. E., & Durgin, T. L.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2015-07-27
- Volume
- 56
- Issue
- 9
- Pages
- 1376-1387
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2104308964
- Cited by
- 252
- References
- 34
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.